Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Living Donor Liver Transplantation in Japanese Registry
โ Scribed by H. Egawa; Y. Ueda; T. Ichida; S. Teramukai; Y. Nakanuma; S. Onishi; H. Tsubouchi
- Book ID
- 114805856
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 335 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1600-6135
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Liver transplantation (LT) is the only therapeutic option for end-stage primary sclerosing cholangitis (PSC), but PSC can recur (rPSC) in some patients after LT. The aim of our study was to evaluate the risk factors associated with rPSC. Between 1989 and 2004, 69 patients receiving transplantation f
Orthotopic liver transplantation (OLT) is the only effective treatment for end-stage liver disease due to primary sclerosing cholangitis (PSC). Recurrence of PSC has recently emerged as a leading cause of allograft failure in the long term. There is limited data on risk factors for recurrence of PSC
We thank Tamura et al. 1 for their thought-provoking letter indicating that there are indeed still a lot of questions to be answered about the recurrence of primary sclerosing cholangitis (PSC). They suggested that a comparison of risk factors and rates of recurrence in living and deceased donor gra